0,00 €
0
🔥 Metabolic & Fat Loss

Cagrilintide

Long-acting amylin analog · long-acting amylin analog

A long-acting amylin receptor agonist researched for its effects on appetite signalling and metabolic regulation, often alongside incretin peptides.

Type
Amylin receptor agonist
Common sizes
10 mg
Research focus
Amylin signalling
Often studied with
Semaglutide · Tirzepatide
🧬

What is Cagrilintide?

Cagrilintide is a long-acting analog of amylin, a hormone co-secreted with insulin. Research examines its activation of amylin and calcitonin receptor pathways and its influence on satiety, gastric emptying, and food-intake signalling, particularly in combination with GLP-1 receptor agonists.

It is a frequently studied complement to incretin research. It is a research-only investigational compound.

🔬

Areas of research

🎯

Amylin agonism

Studied for activation of amylin and calcitonin receptor pathways in models.

🍽️

Satiety signalling

Researched for influence on satiety and food-intake regulation in preclinical work.

⏱️

Extended activity

Examined for a prolonged half-life relative to native amylin in model systems.

⚖️

Metabolic complement

Investigated as a complement to incretin agonists in combined metabolic studies.

💧

In the lab: reconstitution

1

Bring the vial (10 mg) and bacteriostatic water to room temperature.

2

Add bacteriostatic water slowly along the glass wall — the volume you add sets the concentration.

3

Swirl gently (do not shake) until fully clear, then refrigerate at 2–8 °C.

Tip: The Peptide Calculator converts any vial size and water volume into units per syringe mark automatically.

Full storage & handling guide →

🧩

Commonly researched combinations

🔗

Cagrilintide + Semaglutide

Widely studied pairing combining amylin and GLP-1 appetite-signalling pathways.

View stack →
📊

Cagrilintide + Tirzepatide

Studied together to model amylin agonism alongside dual incretin signalling.

View stack →
📚

Selected research studies

Cagrilintide — cagrilintide amylin analogPubMed ↗
Cagrilintide — cagrilintide satiety appetitePubMed ↗
Cagrilintide — amylin receptor agonist metabolicPubMed ↗

Links open a PubMed search for the topic. They point to independent literature and are provided for orientation in a research context only.

💬

FAQ

What is Cagrilintide?

It is a long-acting amylin analog researched for activating amylin and calcitonin receptor pathways, with studied effects on satiety and food-intake signalling in metabolic model systems.

Why is it studied with GLP-1 agonists?

Research pairs it with GLP-1 agonists because amylin and incretin pathways act through distinct mechanisms, allowing investigation of combined effects on appetite and metabolic signalling.

Is Cagrilintide approved?

No. It is an investigational research compound studied in preclinical and exploratory metabolic model systems, with no established approved therapeutic use in this context.

Explore Cagrilintide

See the product, or build a stack around it.

View product →Open Stack-Builder →
For laboratory research only. This guide is provided solely for scientific orientation. Cagrilintide and all products are not intended for human or animal use, nor for the diagnosis, treatment or prevention of any disease. Nothing here is dosing guidance.
© Nephiz Labs · Peptide Guide: Cagrilintide
Research-use information
Shop
Search
Account
Cart
0
Your Cart (0)
Empty CartYour cart is emptyReturn to Shop
Secure Checkout Secure Checkout
Premium Quality Premium Quality
Fast Shipping Fast Shipping